The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Trixeo Aerosphere

AstraZeneca ABEU/1/20/1498/002-003

Main Information

Trade NameTrixeo Aerosphere
Active SubstancesBudesonide micronised
Glycopyrronium bromide
Formoterol fumarate dihydrate (micronised)
Dosage FormPressurised inhalation, suspension
Licence HolderAstraZeneca AB
Licence NumberEU/1/20/1498/002-003

Group Information

ATC CodeR03AL11 formoterol, glycopyrronium bromide and budesonide


License statusAuthorised
Licence Issued09/12/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back